Duchenne and Becker muscular dystrophy
Ultimo aggiornamento 21 Mar 2023
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Ask Patient
- Versione audio
- Aggiungi alle fonti preferite su Google
Muscular dystrophies are a group of genetic conditions characterised by progressive muscle weakness and wasting (atrophy). The Duchenne and Becker types of muscular dystrophy are two related conditions that primarily affect skeletal muscles, which are used for movement, and heart (cardiac) muscle. These forms of muscular dystrophy occur almost exclusively in males.
Scelte video per Condizioni geneticheVideo library
Descrizione
Muscular dystrophies are a group of genetic conditions characterised by progressive muscle weakness and wasting (atrophy). The Duchenne and Becker types of muscular dystrophy are two related conditions that primarily affect skeletal muscles, which are used for movement, and heart (cardiac) muscle. These forms of muscular dystrophy occur almost exclusively in males.
Duchenne and Becker muscular dystrophies have similar signs and symptoms and are caused by different mutations in the same gene. The two conditions differ in their severity, age of onset, and rate of progression. In boys with Duchenne muscular dystrophy, muscle weakness tends to appear in early childhood and worsen rapidly. Affected children may have delayed motor skills, such as sitting, standing, and walking. They are usually wheelchair-dependent by adolescence. The signs and symptoms of Becker muscular dystrophy are usually milder and more varied. In most cases, muscle weakness becomes apparent later in childhood or in adolescence and worsens at a much slower rate.
Both the Duchenne and Becker forms of muscular dystrophy are associated with a heart condition called cardiomyopathy. This form of heart disease weakens the cardiac muscle, preventing the heart from pumping blood efficiently. In both Duchenne and Becker muscular dystrophy, cardiomyopathy typically begins in adolescence. Later, the heart muscle becomes enlarged, and the heart problems develop into a condition known as dilated cardiomyopathy. Signs and symptoms of dilated cardiomyopathy can include an irregular heartbeat (arrhythmia), shortness of breath, extreme tiredness (fatigue), and swelling of the legs and feet. These heart problems worsen rapidly and become life-threatening in most cases. Males with Duchenne muscular dystrophy typically live into their twenties, while males with Becker muscular dystrophy can survive into their forties or beyond.
A related condition called X-linked dilated cardiomyopathy is a form of heart disease caused by mutations in the same gene as Duchenne and Becker muscular dystrophy, and it is sometimes classified as subclinical Becker muscular dystrophy. People with X-linked dilated cardiomyopathy typically do not have any skeletal muscle weakness or wasting, although they may have subtle changes in their skeletal muscle cells that are detectable through laboratory testing.
Modelli di ereditarietà
The source lists the following possible inheritance patterns: X-linked recessive. More than one pattern can apply in different cases.
Related genes
Altri nomi
DBMD
Duchenne/Becker muscular dystrophy
Muscular dystrophy, Duchenne and Becker types
Muscular dystrophy, pseudohypertrophic
Related patient information and medicines

Patient information leaflet
Distrofia muscolare
Muscular dystrophy is an inherited (genetic) disorder causing muscle weakness. Muscular dystrophy (MD) is the name given to a group of disorders which cause progressive muscle weakness (meaning it gets worse over time). Types of muscular dystrophy muscle weakness in types of dystrophy muscle weakness in types of dystrophy Duchenne muscular.

Patient information leaflet
Debolezza muscolare
This leaflet looks at types of muscle weakness and discusses the wide range of problems which can cause them. Rare causes of muscular weakness Genetic conditions affecting muscles Muscular dystrophies : These are inherited diseases which af... They are rare disorders but the best known and most common is Duchenne muscular dystrophy Duchenne.

Patient information leaflet
distrofia muscolare di Duchenne
distrofia muscolare di Duchenne è a condition which causes progressive muscle weakness. It starts in childhood and may be noticed when a child has difficulty standing up, climbing or running. It is a genetic condition and can be inherited. What is Duchenne muscular dystrophy. Duchenne muscular dystrophy (DMD) is an inherited (genetic) condition which.

Patient information leaflet
Test genetici
Note : the information below is a general guide only. It can identify changes in the number of chromosomes ( for example, Down's syndrome Down's syndrome in wh... Fluorescent in situ hybridisation (FISH) analysis - this test looks at certain parts of the chromosomes and can detect very small pieces of chromosomes that are either missing or extra (.

Patient information leaflet
Campionamento dei villi coriali
If you have, or your partner has, a genetic disorder, or are carriers for a genetic disorder that could be passed on to the baby. Examples include sickle cell anaemia Sickle cell disease , thalassaemia Thalassaemia , cystic fibrosis Cystic fibrosis or Duchenne muscular dystrophy Duchenne muscular dystrophy. CVS is usually carried out between the.

Patient information leaflet
Amniocentesi
The most common reason for a pregnant woman to be offered amniocentesis is to see if a developing baby has a chromosomal disorder such as Down's syndrome. If you have, or your partner has, a genetic disorder, or are carrie... Examples include sickle cell anaemia Sickle cell disease , thalassaemia Thalassaemia , cystic fibrosis Cystic fibrosis and.
Ulteriori letture e riferimenti
- Duchenne and Becker muscular dystrophy; MedlinePlus, National Library of Medicine.
- Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010 Jan;9(1):77-93. doi: 10.1016/S1474-4422(09)70271-6. Epub 2009 Nov 27.
- Deconinck N, Dan B. Pathophysiology of duchenne muscular dystrophy: current hypotheses. Pediatr Neurol. 2007 Jan;36(1):1-7. doi: 10.1016/j.pediatrneurol.2006.09.016.
- Duvuru R, Cunningham T, Colvin MK, Veerapandiyan A. Dystrophinopathies. 2000 Sep 5 [updated 2026 Sep 10]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1119/
- Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord. 2014 Jun;24(6):482-91. doi: 10.1016/j.nmd.2014.03.008. Epub 2014 Mar 22.
- Verma S, Anziska Y, Cracco J. Review of Duchenne muscular dystrophy (DMD) for the pediatricians in the community. Clin Pediatr (Phila). 2010 Nov;49(11):1011-7. doi: 10.1177/0009922810378738. Epub 2010 Aug 19. No abstract available.
- Wein N, Alfano L, Flanigan KM. Genetics and emerging treatments for Duchenne and Becker muscular dystrophy. Pediatr Clin North Am. 2015 Jun;62(3):723-42. doi: 10.1016/j.pcl.2015.03.008. Epub 2015 Apr 20.
Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.
Iscriviti alla newsletter di Patient
La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.

